Tubo ROTILABO® FEP, 8,0 mm, 10,0 mm, 5 m, 5 m

Methyl 4,5-dihydroxypicolinate, 95.0%, 500mg

1-[(tert-butoxy)carbonyl]-2-methylazetidine-3-carboxylic acid, 95.0%, 1g

Ethyl 5-ethoxy-2-methylbenzoate, 98%, 250mg

mTOR Inhibitor-1>98.0%(HPLC)25mg

4-(6-Methylpyridin-2-yl)morpholine, 95%, 5g

6-Bromopyrazolo[1.5.-a]-pyrimidine-3-carboxylic acid, 95.0%, 250mg

Dithieno[3,2-c:2',3'-e]oxepine-4,6-dione>98.0%(GC)(T)5g

3-Carboxy-4-fluorophenylboronic acid, 97.0%, 5g

Colonna capillare per GC ROTI®Cap-5, 25 m, 0,25 mm, 0,25 µm, 1 Pezzo(i)

1,2-Dimethyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-benzo[d]imidazole, 98%, 100mg

2-Methoxy-4-(trifluoromethyl)benzyl bromide, 95.0%, 10g

4-(Aminomethyl)pyridin-2(1H)-one hydrochloride, 95.0%, 1g